• Gap19 for Reproducible Cx43 Assays

  2026-09-18

  Learn how Gap19 (SKU B4919), a selective connexin 43 hemichannel blocker, can clarify Cx43-dependent effects in viability, ATP-release, neuroprotection, and inflammation assays. The article provides scenario-based dosing, handling, interpretation, and supplier-selection guidance grounded in product data and primary literature.

• Exogenous NADH Enhances Aminoglycoside Killing

  2026-09-18

  This 2024 Virulence study shows that exogenous NADH can reprogram Edwardsiella tarda metabolism, increase ATP availability, and strengthen the bactericidal activity of neomycin and related antibiotics. Its main contribution is to frame bacterial metabolic state as an experimentally adjustable determinant of antibiotic efficacy, while also identifying important limits for translation across strains and settings.

• DIDS and the Cell-Biological Origins of Metastasis

  2026-09-17

  DIDS offers a mechanistic bridge between chloride transport, cell-death recovery, ER stress, and prometastatic state formation—if researchers design around its pleiotropy.

• Lactate Workflows for Metabolic–Immune Research

  2026-09-17

  Lactate can serve as both a quantitative readout of glycolytic activity and a controlled metabolic signal in cell, hypoxia, mitochondrial, and tumor–immune experiments. This practical guide presents compartment-aware workflows, assay controls, and troubleshooting strategies informed by a recent colorectal cancer study linking the NAT1–ENO1–lactate axis to PD-L1 stability.

• Streptavidin-Cy3: Assay Design for Barrier Biology

  2026-09-16

  Streptavidin-Cy3 combines high-affinity biotin capture with bright Cy3 fluorescence for spatially complex assays. This guide shows how to adapt a streptavidin cy3 conjugate to dynamic, barrier-rich samples while controlling accessibility, background, spectral overlap, and interpretation.

• HyperScript First-Strand cDNA Synthesis Kit Guide

  2026-09-16

  Build more reliable gene-expression workflows for low-abundance transcripts, structured RNA, and long cDNA targets with the HyperScript First-Strand cDNA Synthesis Kit. This practical guide connects primer selection, reverse-transcription conditions, and troubleshooting to biomarker validation workflows such as FOXM1 analysis in female lung adenocarcinoma.

• TEAD, Ferroptosis, and HCC: Study Insights

  2026-09-15

  This study combined multi-database bioinformatics with cell-based validation to identify TEAD2 and TEAD4 as clinically relevant factors in hepatocellular carcinoma. Its most important mechanistic finding is that TEAD2 loss promotes iron accumulation and oxidative cell death, linking Hippo pathway transcriptional control with ferroptosis and HCC prognosis.

• 3-Aminobenzamide: PARP Inhibition Workflows

  2026-09-15

  3-Aminobenzamide (PARP-IN-1) supports controlled studies of oxidative stress, endothelial dysfunction, diabetic nephropathy, and PARP-dependent innate immunity. This practical guide connects assay design, dose optimization, functional readouts, and troubleshooting while distinguishing product specifications from literature-derived findings.

• DIDS: Workflows for Chloride and Tumor Studies

  2026-09-14

  DIDS enables mechanism-focused studies of chloride transport, calcium-activated chloride currents, TRPV1 signaling, and tumor-cell survival after lethal stress. This practical guide connects quantified channel activity with reproducible dosing, solubility control, and assays for prometastatic cell states.

• Perospirone: From Receptors to Vascular Kv1.5

  2026-09-14

  Perospirone (SM-9018 freebase) offers a powerful translational model for connecting serotonergic and dopaminergic receptor pharmacology with vascular ion-channel biology. This article outlines how to use the compound in schizophrenia research, neuropsychiatric disorder models, and carefully bounded cardiovascular investigations.

• Sodium Picosulfate in Gut–Brain Research

  2026-09-13

  Sodium Picosulfate provides a controllable perturbation for studying intestinal fluid handling, stool endpoints, and gut–liver–brain interactions. This workflow-focused guide pairs formulation controls with regional PET readouts while clearly separating product-enabled experiments from findings demonstrated in chronic hepatic encephalopathy research.

• Jasplakinolide B7189 for Reliable Cell Assays

  2026-09-12

  This scenario-based guide explains how Jasplakinolide (SKU B7189) can help researchers interpret actin-dependent changes in viability, proliferation, and cytotoxicity assays. It covers assay compatibility, solution handling, protocol optimization, data interpretation, and practical supplier-selection criteria.

• ISRIB (trans-isomer) for ISR Research Workflows

  2026-09-11

  ISRIB (trans-isomer) gives researchers a controllable way to test whether ISR activation is a driver of translation loss, ER-stress apoptosis, or memory deterioration. Its strongest use-case is timing-sensitive pathway intervention, linking cellular ATF4 biology with inflammation-associated forgetting models while preserving clear preclinical boundaries.

• HLTP1 Targets JNK in Liver Ischemia-Reperfusion

  2026-09-11

  A 2026 World Journal of Gastroenterology study used peptidomics of human liver-transplant samples to identify human liver transplantation peptide 1 (HLTP1), a candidate hepatoprotective peptide for hepatic ischemia-reperfusion injury. Mouse and AML12-cell experiments linked its protective activity to reduced Jun N-terminal kinase phosphorylation and apoptosis, while JNK activation reversed the benefit.

• 3-Deazaneplanocin: A Stratified Translational Path

  2026-09-10

  3-Deazaneplanocin (DZNep) connects SAHH disruption with EZH2-associated chromatin remodeling, offering translational researchers a framework for studying apoptosis, tumor-initiating cells, and context-dependent epigenetic vulnerability.

7896 records 1/527 page Next 12345 下5页 Last page